Opinion

Video

Recent Data on Bimekizumab for Hidradenitis Suppurativa

Vivian Shi, MD, FAAD, reviews recent phase 3 data on bimekizumab, a biologic therapy for patients with hidradenitis suppurativa.

Related Videos
1 expert is featured in this series.
Steven Daniel Daveluy, MD, FAAD
1 expert is featured in this series.
Elizabeth Jones, MD, FAAD
1 expert is featured in this series.
Brittany Craiglow, MD, FAAD
Lawrence Eichenfield, MD, FAAD
1 expert is featured in this series.
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo